Ethics and Law

Confronting pandemics and improving health in low-income countries requires ambitious public health plans. Global health responses to HIV/AIDS and multidrug resistant tuberculosis can provide guidance on how to garner public support and gain financial and political commitments to implement large-scale public health interventions and systems. In this session, experts discussed what it takes to finance and operationalize major public health programs.

Panelists

• Jim Yong Kim, MD, PhD,Vice Chairman and Partner, Global Infrastructure Partners and Former President (2021-19), The World Bank Group
• Teeb Al-Samarral, MD, Director of Science and Policy Office of the Surgeon General
• Prashant Yadav, PhD, MBA, Lecturer on Global Health and Social Medicine, Harvard Medical School
• Moderator: Rebecca Weintraub, MD, Founder, Director, Global Health Delivery Project, Harvard University and Assistant Professor of Global Health and Social Medicine, Harvard Medical School

---

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.

They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women’s Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.